Case study of tacrolimus as an effective treatment for idiopathic membranous glomerulonephritis in pregnancy

Research output: Contribution to journalArticle

Abstract

Background: Tacrolimus has been used in pregnant women following transplantation and for management of lupus nephritis. We report a case of successful control of nephrotic syndrome due to membranous glomerulonephritis during pregnancy using tacrolimus. Case report: A 26-year-old female presented with severe nephrotic syndrome in her first pregnancy. Post-partum renal biopsy confirmed idiopathic membranous glomerulonephritis. She had persistent proteinuria of 6 g/day with hypoalbuminaemia despite angiotensin receptor blockade. Treatment with tacrolimus monotherapy led to remission of proteinuria, three months prior to conceiving again. She maintained remission with tacrolimus therapy in pregnancy, resulting in a successful birth outcome. Conclusions: Membranous glomerulonephritis can be successfully and safely managed with tacrolimus monotherapy during pregnancy. This provides an alternative immunosuppressant with a favourable side effect profile suitable for use in women planning a pregnancy when other immunosuppressive drugs should be avoided.

LanguageEnglish
JournalObstetric Medicine
DOIs
Publication statusAccepted/In press - 1 Jan 2019
Externally publishedYes

Keywords

  • Membranous glomerulonephritis
  • nephrotic syndrome
  • proteinuria
  • tacrolimus

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

@article{2fb699e6c891406f87cb4dcbc8301957,
title = "Case study of tacrolimus as an effective treatment for idiopathic membranous glomerulonephritis in pregnancy",
abstract = "Background: Tacrolimus has been used in pregnant women following transplantation and for management of lupus nephritis. We report a case of successful control of nephrotic syndrome due to membranous glomerulonephritis during pregnancy using tacrolimus. Case report: A 26-year-old female presented with severe nephrotic syndrome in her first pregnancy. Post-partum renal biopsy confirmed idiopathic membranous glomerulonephritis. She had persistent proteinuria of 6 g/day with hypoalbuminaemia despite angiotensin receptor blockade. Treatment with tacrolimus monotherapy led to remission of proteinuria, three months prior to conceiving again. She maintained remission with tacrolimus therapy in pregnancy, resulting in a successful birth outcome. Conclusions: Membranous glomerulonephritis can be successfully and safely managed with tacrolimus monotherapy during pregnancy. This provides an alternative immunosuppressant with a favourable side effect profile suitable for use in women planning a pregnancy when other immunosuppressive drugs should be avoided.",
keywords = "Membranous glomerulonephritis, nephrotic syndrome, proteinuria, tacrolimus",
author = "Irish, {G. L.} and Shilpanjali Jesudason",
year = "2019",
month = "1",
day = "1",
doi = "10.1177/1753495X18816923",
language = "English",
journal = "Obstetric Medicine",
issn = "1753-495X",
publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Case study of tacrolimus as an effective treatment for idiopathic membranous glomerulonephritis in pregnancy

AU - Irish, G. L.

AU - Jesudason, Shilpanjali

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Tacrolimus has been used in pregnant women following transplantation and for management of lupus nephritis. We report a case of successful control of nephrotic syndrome due to membranous glomerulonephritis during pregnancy using tacrolimus. Case report: A 26-year-old female presented with severe nephrotic syndrome in her first pregnancy. Post-partum renal biopsy confirmed idiopathic membranous glomerulonephritis. She had persistent proteinuria of 6 g/day with hypoalbuminaemia despite angiotensin receptor blockade. Treatment with tacrolimus monotherapy led to remission of proteinuria, three months prior to conceiving again. She maintained remission with tacrolimus therapy in pregnancy, resulting in a successful birth outcome. Conclusions: Membranous glomerulonephritis can be successfully and safely managed with tacrolimus monotherapy during pregnancy. This provides an alternative immunosuppressant with a favourable side effect profile suitable for use in women planning a pregnancy when other immunosuppressive drugs should be avoided.

AB - Background: Tacrolimus has been used in pregnant women following transplantation and for management of lupus nephritis. We report a case of successful control of nephrotic syndrome due to membranous glomerulonephritis during pregnancy using tacrolimus. Case report: A 26-year-old female presented with severe nephrotic syndrome in her first pregnancy. Post-partum renal biopsy confirmed idiopathic membranous glomerulonephritis. She had persistent proteinuria of 6 g/day with hypoalbuminaemia despite angiotensin receptor blockade. Treatment with tacrolimus monotherapy led to remission of proteinuria, three months prior to conceiving again. She maintained remission with tacrolimus therapy in pregnancy, resulting in a successful birth outcome. Conclusions: Membranous glomerulonephritis can be successfully and safely managed with tacrolimus monotherapy during pregnancy. This provides an alternative immunosuppressant with a favourable side effect profile suitable for use in women planning a pregnancy when other immunosuppressive drugs should be avoided.

KW - Membranous glomerulonephritis

KW - nephrotic syndrome

KW - proteinuria

KW - tacrolimus

UR - http://www.scopus.com/inward/record.url?scp=85060640646&partnerID=8YFLogxK

U2 - 10.1177/1753495X18816923

DO - 10.1177/1753495X18816923

M3 - Article

JO - Obstetric Medicine

T2 - Obstetric Medicine

JF - Obstetric Medicine

SN - 1753-495X

ER -